Herbal hope: ashwagandha trial targets minority stress in LGBTQ+ community

NCT ID NCT07441070

Recruiting now Symptom relief Sponsor: SF Research Institute, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a daily ashwagandha supplement can lower stress, anxiety, and improve sleep in 80 LGBTQ+ adults aged 18-45 who report high stress. Participants take either ashwagandha capsules or a placebo for 8 weeks, and researchers track changes using questionnaires and a stress hormone test. The goal is to find a safe, non-drug option for managing the chronic stress linked to stigma and discrimination.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ashwagandha root extract (dietary supplement)
What this could lead to: If it works, this could offer a natural, non-prescription option to help LGBTQ+ adults manage stress and sleep problems.
What could go wrong: This is a small, early-stage study. Supplements are not strictly regulated, and results may not apply to everyone. The placebo effect could be strong.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Stress, Psychological

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY MINORITY STRESS PSYCHOLOGICAL STRESS

Contacts and locations

Locations

San Francisco Research Institute
RECRUITING

San Francisco, California, 94132, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.